Effectiveness of Trimetazidine in Patients with Stable Angina Pectoris of Various Durations: Results from ODA
Abstract Introduction Trimetazidine (TMZ) is an antianginal agent that acts directly at the myocardial cell level and which is now available in a once-daily (od) formulation. Methods ODA, a 3-month, observational, multicenter study in Russia, assessed the effectiveness and tolerability of TMZ 80 mg...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Adis, Springer Healthcare
2020-05-01
|
| Col·lecció: | Cardiology and Therapy |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1007/s40119-020-00174-7 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|